Treatment patterns and clinical outcomes in elderly patients with HER2-positive metastatic breast cancer from the registHER observational study.

Breast Cancer Res Treat · 2012 · PMC3439611 · PMID 22923238

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a possible trendno p-value reported

Conclusions Consistent with data from prospective randomized phase III trials [ 29 , 30 ], these real-world data from the registHER study suggest improved PFS across all age groups, with OS benefits for the younger and older groups, and a possible trend for OS in the elderly.

also in 948 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.